Access cutting-edge candida infection treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access candida infection specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related candida infection treatment provided free
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-threatening fungal infection caused by several species of yeast called Candida. The study is seeking patients who have a diagnosis of candidemia and/or invasive candidiasis. Two-thirds of all patients will receive the study medication fosmanogepix Intravenous (IV) infusion followed by optional fosma
Sponsor: Basilea Pharmaceutica
Check if you qualify for this candida infection clinical trial in Minneapolis, MN
If you're searching for candida infection treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced candida infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.